Plain-English translation of NCT06665945 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ovarian Cancer research guide →The SENTRY Study is testing whether analyzing RNA (genetic material) from platelets in your blood can help doctors accurately diagnose ovarian cancer. Researchers have developed a unique approach that showed promise in earlier studies, and now they want to confirm it works in real patients like you. If successful, this blood test could help catch ovarian cancer earlier when it's easier to treat.
Currently, diagnosing ovarian cancer often requires surgery or invasive procedures to get a definitive answer. A simple blood test would be faster, less invasive, and could help doctors identify ovarian cancer earlier—potentially improving outcomes for patients.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have a blood sample drawn from your arm—similar to a routine blood test. The researchers will analyze the RNA in your platelets to see if the new test can correctly identify whether you have ovarian cancer. You may also be asked to share some basic health information. The study is designed to fit around your regular cancer care appointments.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States